Drug Cos. Lose Bid to Stay Chicago's Opioid Marketing Suit

Law360, Los Angeles (September 29, 2016, 9:49 PM EDT) -- Some of the nation’s leading pharmaceutical companies on Thursday lost a bid to dodge consumer fraud claims from the city of Chicago over an alleged scheme to sell opiates despite their addictive properties, with an Illinois federal judge denying an attempt to stay the case pending FDA reviews.

Chicago sued Teva Pharmaceuticals, Purdue Pharma Inc. and other drugmakers in 2014, saying they misled doctors and the public about the addictive nature of opiates and pushed prescriptions despite known dangers of addiction.

The pharmaceutical companies in November tried to dismiss the city’s 325-page second amended complaint on multiple fronts, including trying to stay...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!